ИСТИНА

Encadum is a medical product, a wide spectrum immunomodulator. On the data of the Moscow Helmholtz Research Institute of Eye Diseases, Russia, using the preparation Encad since 1970, this preparation is practically the unique remedy detaining progressing of dystrophic process at pigmentary abiotrophy of a retina, a heavy hereditary disease, resulting in impaired vision and loss of sight. The scope of the preparation can be essentially expanded. Clinico-endoscopic observations carried out lately allow drawing a conclusion on efficiency of therapeutic effect of Encad on the processes of reparative regeneration of tissues and expediency of inclusion of the given preparation in a complex of medical actions at stomach ulcer and duodenal ulcer patients. In dermatology on the basis of clinical re-searches carried out in the Central Scientific and Research Dermatovenerologic Institute the efficiency of treatment for widespread psoriasis with the preparation Encad in a combination to traditional photochemotherapy is established. The given complex method of treatment allows to reduce a total doze of irradiation and to shorten the terms of treatment and also to increase the duration of clinical remission. Efficiency of use of the preparation for nervous-muscular diseases and an insult is protected by a number of patents of the Russian Federation. Now the medical preparation Encad is permitted for medical application for treatment for immunodeficiency - Shegren disease, at degenerate diseases of nervous - muscular system: hereditary forms of myopathies (early stages), at congenital and acquired myopathic syndromes, different forms of neural amyotrophies, consequences of neuroinfections, spinal amyotrophies and tapetoretinal degenerations. We have got the patent of the USA for the method of preparing a mixture of ribonucleotides US №5064758, Nov.12, 1991. The pre-production model of the preparation Encad manufactured in this new way (RU №2274658, 20.04.2006) has passed the tests according to the pharmacopeia.